SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Benjamin M. Brainard, Robert Goggs, Jose L. Mendez-Angulo, Margaret C. Mudge, Alan G. Ralph, Bo Wiinberg, Systematic evaluation of evidence on veterinary viscoelastic testing Part 5: Nonstandard assays, Journal of Veterinary Emergency and Critical Care, 2014, 24, 1
  2. 2
    T.G. Walsh, M.C. Berndt, N. Carrim, J. Cowman, D. Kenny, P. Metharom, The role of Nox1 and Nox2 in GPVI-dependent platelet activation and thrombus formation, Redox Biology, 2014, 2, 178

    CrossRef

  3. 3
    M. Ungerer, G. Münch, Novel antiplatelet drugs in clinical development, Thrombosis and Haemostasis, 2013, 110, 5, 868

    CrossRef

  4. 4
    Jolanta M. Siller-Matula, Marcel Francesconi, Cornelia Dechant, Bernd Jilma, Gerald Maurer, Georg Delle-Karth, Ghazaleh Gouya, Katharina Ruzicka, Andrea Podczeck-Schweighofer, Günter Christ, Personalized antiplatelet treatment after percutaneous coronary intervention: The MADONNA study, International Journal of Cardiology, 2013, 167, 5, 2018

    CrossRef

  5. 5
    Susanne M. Picker, Platelet Function in Ischemic Heart Disease, Journal of Cardiovascular Pharmacology, 2013, 61, 2, 166

    CrossRef

  6. 6
    E. Mahla, R. Raggam, W. Toller, Platelet function testing to time surgery in patients on dual antiplatelet therapy?, Hämostaseologie, 2013, 34, 1, 40

    CrossRef

  7. 7
    Marco Cattaneo, Platelets, 2013,

    CrossRef

  8. 8
    Paul A. Gurbel, Udaya S. Tantry, Platelets, 2013,

    CrossRef

  9. 9
    Mukesh Singh, Tejaskumar Shah, Sasikanth Adigopula, Janos Molnar, Aziz Ahmed, Sandeep Khosla, Rohit Arora, CYP2C19*2/ABCB1-C3435T polymorphism and risk of cardiovascular events in coronary artery disease patients on clopidogrel: Is clinical testing helpful?, Indian Heart Journal, 2012, 64, 4, 341

    CrossRef

  10. 10
    Gillian Stephens, Ming He, Connie Wong, Marzena Jurek, Hans-Christian Luedemann, Golnaz Shapurian, Kevin Munnelly, Craig Muir, Pamela B Conley, David R Phillips, Patrick Andre, Development of a perfusion chamber assay to study in real time the kinetics of thrombosis and the antithrombotic characteristics of antiplatelet drugs, Thrombosis Journal, 2012, 10, 1, 11

    CrossRef

  11. 11
    K. A. L. Müller, T. Geisler, M. Gawaz, Elinogrel, an orally and intravenously available ADP-receptor antagonist, Hämostaseologie, 2012, 32, 3, 191

    CrossRef

  12. 12
    Kathleen A. Packard, Jennifer A. Campbell, Jon T. Knezevich, Estella M. Davis, Emerging Antiplatelet Therapy for Coronary Artery Disease and Acute Coronary Syndrome, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2012, 32, 3
  13. 13
    David Della-Morte, Fiorella Guadagni, Raffaele Palmirotta, Gianluca Testa, Valeria Caso, Maurizio Paciaroni, Pasquale Abete, Franco Rengo, Patrizia Ferroni, Ralph L Sacco, Tatjana Rundek, Genetics of ischemic stroke, stroke-related risk factors, stroke precursors and treatments, Pharmacogenomics, 2012, 13, 5, 595

    CrossRef

  14. 14
    In-Suk Kim, Young-Hoon Jeong, Yongwhi Park, Seong-Eun Yoon, Tae Jung Kwon, Jeong Rang Park, Seok-Jae Hwang, Eun-Ha Koh, Choong Hwan Kwak, Jin-Yong Hwang, Sunjoo Kim, Interaction analysis between genetic polymorphisms and pharmacodynamic effect in patients treated with adjunctive cilostazol to dual antiplatelet therapy: results of the ACCEL-TRIPLE (Accelerated Platelet Inhibition by Triple Antiplatelet Therapy According to Gene Polymorphism) study, British Journal of Clinical Pharmacology, 2012, 73, 4
  15. 15
    Rachel F Power, Brian G Hynes, Darragh Moran, Hatim Yagoub, Gary Kiernan, Nicholas J Ruggiero, Thomas J Kiernan, Modern antiplatelet agents in coronary artery disease, Expert Review of Cardiovascular Therapy, 2012, 10, 10, 1261

    CrossRef

  16. 16
    Guang-Ming Tan, Yat-Yin Lam, Bryan P. Yan, Novel Platelet ADP P2Y12 Inhibitors in the Treatment of Acute Coronary Syndrome, Cardiovascular Therapeutics, 2012, 30, 4
  17. 17
    David P. Faxon, Optimizing antiplatelet therapy in acute coronary syndrome and percutaneous coronary intervention, Catheterization and Cardiovascular Interventions, 2012, 79, 2
  18. 18
    Fatemeh Moheimani, Denise E. Jackson, P2Y12 receptor: platelet thrombus formation and medical interventions, International Journal of Hematology, 2012, 96, 5, 572

    CrossRef

  19. 19
    Kallirroi I Kalantzi, Maria E Tsoumani, Ioannis A Goudevenos, Alexandros D Tselepis, Pharmacodynamic properties of antiplatelet agents: current knowledge and future perspectives, Expert Review of Clinical Pharmacology, 2012, 5, 3, 319

    CrossRef

  20. 20
    N. Mallouk, C. Labruyere, J.-L. Reny, C. Chapelle, M. Piot, P. Fontana, J.-C. Gris, X. Delavenne, P. Mismetti, S. Laporte, Prevalence of poor biological response to clopidogrel, Thrombosis and Haemostasis, 2012, 107, 3, 494

    CrossRef

  21. 21
    Mark J Antonino, Young-Hoon Jeong, Udaya S Tantry, Kevin P Bliden, Paul A Gurbel, Role of genotype-based personalized antiplatelet therapy in the era of potent P2Y12receptor inhibitors, Expert Review of Cardiovascular Therapy, 2012, 10, 8, 1011

    CrossRef

  22. 22
    Gillian Stephens, Jan Tauscher, Patrick Andre, Fabian P. Siegel, David R. Phillips, Petro E. Petrides, Sub-optimal inhibition of thrombus formation ex vivo by aspirin in patients with primary thrombocythaemia, British Journal of Haematology, 2012, 159, 2
  23. 23
    Dominick J. Angiolillo, The Evolution of Antiplatelet Therapy in the Treatment of Acute Coronary Syndromes, Drugs, 2012, 72, 16, 2087

    CrossRef

  24. 24
    A. D. Michelson, Advances in Antiplatelet Therapy, Hematology, 2011, 2011, 1, 62

    CrossRef

  25. 25
    Richard Hall, C. David Mazer, Antiplatelet Drugs, Anesthesia & Analgesia, 2011, 112, 2, 292

    CrossRef

  26. 26
    Joseph A Jakubowski, Beyond platelet functional testing: value in the aggregate, Biomarkers in Medicine, 2011, 5, 1, 5

    CrossRef

  27. 27
    J. A. Jakubowski, N. Bourguet, D. Boulay-Moine, A. Sugidachi, S. Yamaguchi, P. Barragan, C. Zhou, M. Moulard, Comparison of a new ELISA assay with the flow cytometric assay for platelet vasodilator-associated stimulated phosphoprotein (VASP) phosphorylation in whole blood to assess P2Y12 inhibition, Thrombosis and Haemostasis, 2011, 107, 2, 388

    CrossRef

  28. 28
    Michelle T. Martin, Sarah A. Spinler, Edith A. Nutescu, Emerging Antiplatelet Therapies in Percutaneous Coronary Intervention: A Focus on Prasugrel, Clinical Therapeutics, 2011, 33, 4, 425

    CrossRef

  29. 29
    Marian A. Packham, Margaret L. Rand, Historical perspective on ADP-induced platelet activation, Purinergic Signalling, 2011, 7, 3, 283

    CrossRef

  30. 30
    Harvey D. White, Oral antiplatelet therapy for atherothrombotic disease: Current evidence and new directions, American Heart Journal, 2011, 161, 3, 450

    CrossRef

  31. 31
    Tong Yin, Toshiyuki Miyata, Pharmacogenomics of clopidogrel: Evidence and perspectives, Thrombosis Research, 2011, 128, 4, 307

    CrossRef

  32. 32
    R. F. Storey, Pharmacology and clinical trials of reversibly-binding P2Y12 inhibitors, Thrombosis and Haemostasis, 2011, 105, Suppl. 1, S75

    CrossRef

  33. 33
    Isabell Bernlochner, Robert A Byrne, Adnan Kastrati, Dirk Sibbing, The future of platelet function testing to guide therapy in clopidogrel low and enhanced responders, Expert Review of Cardiovascular Therapy, 2011, 9, 8, 999

    CrossRef

  34. 34
    Tariq Ahmad, Deepak Voora, Richard C. Becker, The pharmacogenetics of antiplatelet agents: towards personalized therapy?, Nature Reviews Cardiology, 2011, 8, 10, 560

    CrossRef

  35. 35
    Paul A. Gurbel, Udaya S. Tantry, Acceptance of High Platelet Reactivity as a Risk Factor, JACC: Cardiovascular Interventions, 2010, 3, 10, 1008

    CrossRef

  36. 36
    David R. Holmes, Gregory J. Dehmer, Sanjay Kaul, Dana Leifer, Patrick T. O'Gara, C. Michael Stein, ACCF/AHA Clopidogrel Clinical Alert: Approaches to the FDA “Boxed Warning”, Journal of the American College of Cardiology, 2010, 56, 4, 321

    CrossRef

  37. 37
    Laurent Bonello, Udaya S. Tantry, Rossella Marcucci, Ruediger Blindt, Dominick J. Angiolillo, Richard Becker, Deepak L. Bhatt, Marco Cattaneo, Jean Philippe Collet, Thomas Cuisset, Christian Gachet, Gilles Montalescot, Lisa K. Jennings, Dean Kereiakes, Dirk Sibbing, Dietmar Trenk, Jochem W. Van Werkum, Franck Paganelli, Matthew J. Price, Ron Waksman, Paul A. Gurbel, Consensus and Future Directions on the Definition of High On-Treatment Platelet Reactivity to Adenosine Diphosphate, Journal of the American College of Cardiology, 2010, 56, 12, 919

    CrossRef

  38. 38
    Elisabeth Mahla, Helfried Metzler, Udaya S. Tantry, Paul A. Gurbel, Controversies in Oral Antiplatelet Therapy in Patients Undergoing Aortocoronary Bypass Surgery, The Annals of Thoracic Surgery, 2010, 90, 3, 1040

    CrossRef

  39. 39
    Masafumi Ueno, Sunil V Rao, Dominick J Angiolillo, Elinogrel: pharmacological principles, preclinical and early phase clinical testing, Future Cardiology, 2010, 6, 4, 445

    CrossRef

  40. 40
    Paul A. Gurbel, Udaya S. Tantry, Alan R. Shuldiner, Dean J. Kereiakes, Genotyping, Journal of the American College of Cardiology, 2010, 56, 2, 112

    CrossRef

  41. 41
    David Vivas, Dominick J. Angiolillo, Platelet P2Y12 Receptor Inhibition, American Journal Cardiovascular Drugs, 2010, 10, 4, 217

    CrossRef

  42. 42
    Sergio Leonardi, Sunil V. Rao, Robert A. Harrington, Deepak L. Bhatt, C. Michael Gibson, Matthew T. Roe, Janusz Kochman, Kurt Huber, Uwe Zeymer, Mina Madan, Daniel D. Gretler, Matthew W. McClure, Gayle E. Paynter, Vivian Thompson, Robert C. Welsh, Rationale and design of the randomized, double-blind trial testing INtraveNous and Oral administration of elinogrel, a selective and reversible P2Y12-receptor inhibitor, versus clopidogrel to eVAluate Tolerability and Efficacy in nonurgent Percutaneous Coronary Interventions patients (INNOVATE-PCI), American Heart Journal, 2010, 160, 1, 65

    CrossRef

  43. 43
    Marco Cattaneo, Gian Marco Podda, State of the art of new P2Y12 antagonists, Internal and Emergency Medicine, 2010, 5, 5, 385

    CrossRef

  44. 44
    Łukasz A Małek, Adam Witkowski, Use of antiplatelet therapies during primary percutaneous coronary intervention for acute myocardial infarction, Interventional Cardiology, 2010, 2, 5, 705

    CrossRef

  45. 45
    Matthew J. Chung, Sunil V. Rao, Elinogrel,
  46. 46
    Sylvia Farzi, Elisabeth Mahla, Helfried Metzler, Andrea Berghold, The effect of preoperative treatment of P2Y12 receptor antagonists on perioperative bleeding and mortality in patients treated with coronary artery bypass grafting (CABG), The Cochrane Library,
  47. 47
    Joseph A. Jakubowski, Atsuhiro Sugidachi, Thienopyridyl and Direct-Acting P2Y12 Receptor Antagonist Antiplatelet Drugs,